Stop scrolling trades.
Start getting briefed.
Free. Daily. Built for horror.
Free forever · Every morning · Unsubscribe anytime
Know what's killing.
Deals, data, moves, money, production. Every dead of morning.
Mike P. Nelson boards Lionsgate's next Saw installment, with James Wan, Jason Blum and Leigh Whannell producing under Blumhouse Atomic Monster after the franchise's return from Twisted Pictures.
Toho’s first IMAX-shot Godzilla sequel opens NYFF’s Spotlight Gala on Sept. 26 before a Nov. 6 North American theatrical rollout; Takashi Yamazaki returns, and Minus One’s $56 million North American run raises the stakes.
DC's Clayface is a $40M R-rated body-horror swing; James Watkins directs from Mike Flanagan and Hossein Amini's script, with Warner Bros. eyeing a low-to-mid $20M opening for Oct. 23, 2026.
U.S. rights acquired for Russell Goldman’s debut psychological thriller; Dark Sky Films sets a nationwide theatrical rollout for spring 2027 after SXSW, with Jamie Lee Curtis producing and the cast led by Britt Lower, Rhea Seehorn, David Dastmalchian and Anna Baryshnikov.
Netflix upgrades The Beast in Me to a second season and locks Howard Gordon to an overall deal; the limited series logged seven weeks in the global Top 10 and nearly 97 million U.S. streaming hours.
Louis McCartney, Jessica Reynolds, Sky Yang and Gabriel Nagy board A24's Anglo-Irish horror No One Is Coming; Ronan Corrigan directs, with Film4 and Screen Ireland co-financing.
Trades, genre press, international outlets, studio newsrooms, festival wires, and 200+ entity feeds. Every signal that matters. Every morning.
Free. Daily. Built for horror.